InvestorsHub Logo
Followers 19
Posts 670
Boards Moderated 0
Alias Born 04/30/2020

Re: None

Tuesday, 10/06/2020 9:30:03 AM

Tuesday, October 06, 2020 9:30:03 AM

Post# of 233118
FDA very impressed with Leronlimab. The very reason they suspended EIND patients is we were taking on so many 60+ it was creating A lot of paperwork and they want trial to be approved and finished as much as shareholders do It saves lives and it’s less work for them if they approve the only drug that reduced mortality.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News